Uses, Dosage & Side Effects: Vitrakvi Capsule
Vitrakvi Capsule
| Generic name | larotrectinib |
|---|---|
| Drug class | Tropomyosin receptor kinase (TRK) inhibitor |
| Forms | Capsules (25 mg and 100 mg), Oral solution (20 mg/mL) |
Vitrakvi is a prescription cancer medicine taken by mouth. It is not a type of chemotherapy. It is used to treat adults and children with solid tumors caused by an abnormal NTRK gene fusion.
Read the full guideUses, dosage, side effects, precautions, and sources, written from the same verified facts.
General information, not medical advice
Your prescriber and the leaflet in your pack know your situation. This page does not.
- Follow your prescriber and the leaflet
- Don't start, stop, or change a dose on your own
- Doses and warnings differ by country and product
Took too much, or feel seriously unwell? Get urgent medical help now.
Facts checked by a personFull disclaimer
